Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ACCUTANE, AEs, Alliance, alopecia, anemia, Angiofibroma, ANR, ARCI, area, areata, Arterial, assay, AUS, autoimmune, begun, belief, bimodal, blinded, block, born, Bosentan, bovine, brain, Brazil, breakthrough, carcinoma, cardiac, caregiver, causality, cell, Century, cerebral, characteristic, Chinese, clearance, clinician, clobetasol, Clostridium, collagen, concordance, Conference, confound, content, contrast, convey, cornea, cornification, correlate, corticosteroid, cream, deletion, diagnosed, diagnostic, dichotomized, difficile, disfigurement, disfiguring, distinct, divisional, DLQI, dominant, dorsal, dual, encephalopathy, endothelin, environment, EOS, EPO, ethanol, evergreen, excretion, eye, FASI, FDASIA, female, fibroblast, fidelity, fissuring, forfeited, Foundation, Franz, freestanding, FTO, futility, gene, GLP, graph, guinea, hardening, heart, hematology, highlighting, Hong, hydration, hypermotility, hyperpigmentation, Hypertension, ID, IMM, inherited, Inline, Interactive, invasion, IPEG, Israel, Itch, ITT, Japan, kidney, Kong, Korea, led, Lichen, liver, lot, LSR, lubrication, male, markedly, melanin, mental, microscopic, migration, mobility, modest, morphea, muscle, NaN, navigate, neurological, NIH, NJ, nodular, notable, NRS, ns, occlusion, ointment, older, outperformed, PAH, pain, painful, pathologic, pathology, PDUFA, PEG, perianal, permeability, perspective, pharmacokinetic, phenotype, phototoxicity, pilot, pin, PK, polyethylene, PP, pre, precursor, predominant, predominantly, prefunded, preliminarily, presence, proliferation, prominent, pruritic, psychiatric, PTE, Pulmonary, questionnaire, rarity, rash, reaction, reauthored, recalcitrant, recapture, refrigerated, renal, resistance, restoration, resubmitted, retinal, retinoid, rheumatic, row, running, Russian, RXLI, SAE, save, sclerotic, scratch, sedative, serum, signal, simple, sixty, skeletal, smooth, steroid, stimulating, subtype, sulfatase, surrogate, synthesizing, tablet, tailor, task, teratogenicity, TMB, tool, top, transglutaminase, Transplacental, tretinoin, tropical, Trough, Ukraine, ultrapotent, underserved, underway, underwriting, unredeemed, USA, vector, visible, visual, vitiligo, vitro, volunteer, vulva, vulvae, Wainwright, Western, withholding, WO, XLRI, XRI, Yale
Filing tables
Filing exhibits
TMBR similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-262391, 333-259830, 333-239216, 333-227262, 333-217419, 333-213627 and 333-201708) on Form S-8 and (Nos. 333-255743, 333-251138, 333-220012, 333-213635 and 333-212015) on Form S-3 of Timber Pharmaceuticals, Inc. and subsidiaries of our report dated March 31, 2022, with respect to the consolidated financial statements as of December 31, 2021 of Timber Pharmaceuticals, Inc.
| |
/s/ KPMG LLP | |
| |
Short Hills, New Jersey | |
March 31, 2022 | |